AI: Are we using it for the right things?

Tools such as the immensely popular ChatGPT and the recently launched Sora help demonstrate the potential of AI to everyday users. On the downside though, they have a pretty large carbon footprint. And once the novelty wears off, the AI tools turn into security nightmares for both users and businesses.

But these user-facing AI tools that have captured the imagination of people are merely the tip of the iceberg. A broader set of stakeholders are making true use of AI’s potential. These trailblazers are pioneering breakthroughs that just wouldn’t be possible without AI.

One of those is attorney Andy Gillin, managing partner at GJEL Accident Attorneys. He tells us how artificial intelligence is revolutionizing the legal profession through the use of predictive coding. Designed to help programmers, lawyers use predictive coding to review and sort through document-heavy cases, which is often a laborious and time-consuming process when done manually.?

“AI can improve the efficiency and accuracy of legal research, contract analysis, and even discovery processes in litigation, saving attorneys countless hours of work,” says Gillin.

Fighting climate change

Then there’s Dr. Kos Galatsis, CEO and CTO of Forensics Detectors. His company is using AI to fight climate change by fine tuning monitoring.

He says using AI helps them analyze weather patterns that allows them to foresee natural disasters. It also helps them optimize energy usage patterns to reduce emissions, and even monitor wildlife to prevent poaching.?

Designing novel treatments

Another interesting use of AI comes from Negev Labs. They are using AI to help us expedite the discovery of novel treatments based on neuroplastogens. According to Ken Belotsky, the CEO and co-founder of Negev Labs, neuroplastogens are molecules inspired by psychedelics that aim to help people suffering from a wide range of diseases.?

Demonstrating the use of AI in the field, Belotsky says they are working on finding new and effective treatments for mental and behavioral disorders such as schizophrenia. Additionally, they are also looking into ophthalmological, inflammatory and other non-neuropsychiatric conditions.

He explains that to effectively use neuroplastogens requires sifting through huge amounts of data. Using AI, specifically big data analytics, helps Negev uncover promising medical researchers and projects in neuroplastogens around the world.?

For the full article, click here.